BRAF and melanoma: Interestingly, in patients with stage IV melanoma, lower frequencies of PD-L1+ PMNs in peripheral blood were associated with improved progression-free survival (PFS) and OS compared to those with higher PD-L1+ PMN frequencies only in BRAF wild-type patient subgroup [116].